Sunday, September 13, 2026

Nikkei 225 Bullish Momentum With A 4% Rise In The Last 5 Sessions

ViaNews Editorial Team

October 13, 2023

Nikkei 225 Bullish Momentum With A 4% Rise In The Last 5 Sessions

(VIANEWS) - Nikkei 225 (N225) has been up by 4.33% for the last 5 sessions. At 21:08 EST on Thursday, 12 October, Nikkei 225 (N225) is $32,422.14.

About Nikkei 225's yearly highs and lows, it's 26.34% up from its 52-week low and 4% down from its 52-week high.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Nikkei 225's is considered to be oversold (<=20).

News about

  • According to Zacks on Wednesday, 11 October, "Avangrid declared a quarterly dividend of 44 cents per share in July 2023, resulting in an annual payout of $1.76.AGR's current dividend yield is 5.84%, better than the Zacks S&P 500 Composite's 1.73%."
  • According to DailyForex on Wednesday, 11 October, "In this context, the S&P 500 appears poised for a continued back-and-forth pattern, underscoring the importance of caution and astute risk management.", "In the end, the S&P 500 confronts a pivotal juncture, testing key resistance levels while contending with the reopening of the bond market. "
  • According to MarketWatch on Wednesday, 11 October, "Walmart's stock has gained 11% in the year to date, while the S&P 500 SPX has gained 13.5%."
  • According to MarketWatch on Wednesday, 11 October, "The stock has gained 8% in the year to date, while the S&P 500 has gained 13.5%."
  • According to MarketWatch on Wednesday, 11 October, "His first-hand experience leading through challenges and opportunities of a changing health care services continuum will help accelerate our integrated care strategy at pace." Humana stock has lost 2.3% year to date through Tuesday, while the Health Care Select Sector ETF has declined 3.5% and the S&P 500 has advanced 13.5%."

More news about Nikkei 225 (N225).

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Chip Boom Lifts Semiconductors as Export-Control Gaps Persist
AI infrastructure demand is fueling a broad semiconductor rally — Broadcom's AI chip revenue and Q4 guidance, Amazon's custom silicon crossing a $25B annual run rate, and bullish analyst calls on Micron and Sandisk tied to a memory chip boom underestimated even by bulls — with ASML rallying on sympathy. That momentum runs alongside unresolved US-China tech tensions: Belgium's arrest of a suspect for stealing chip technology for China and a blacklisted Chinese firm still acquiring Nvidia's top AI chips show export-control enforcement lagging the pace of AI chip demand.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com